Joint (JYNT) Stock Price, News & Analysis

Company Overview

The Joint Corp. operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company provides routine, non-invasive chiropractic care focused on spinal health, mobility and wellness through licensed chiropractors in convenient outpatient locations.

The Joint Chiropractic primarily serves patients through membership and wellness plans, as well as individual visits. Its clinics generally offer services without requiring traditional appointments, and the company supports franchisees with branding, operating systems, technology, marketing and business services.

Founded in 1999 and headquartered in Scottsdale, Arizona, The Joint Corp. has expanded through a combination of franchised and company-owned clinics across the United States. The company’s operations are concentrated in the U.S. market, where it seeks to make chiropractic care more accessible through standardized clinic formats and subscription-based care options.

Key Stats

• Today's Range: $8.12 to $8.23
• 50-Day Range: $7.85 to $8.91
• 52-Week Range: $7.50 to $10.67
• Volume: 31,021 shs
• Average Volume: 81,999 shs
• Market Capitalization: $114.89 million
• P/E Ratio: 30.22
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Joint Stock Analysis - MarketRank™

Joint scored higher than 38% of companies evaluated by MarketBeat, and ranked 704th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Reduce

Consensus Rating

Joint has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Joint has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 103.23%

Earnings Growth

Earnings for Joint are expected to grow by 103.23% in the coming year, from $0.31 to $0.63 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Joint is 30.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of Joint is 30.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.72.

Price to Book Value per Share Ratio

Joint has a P/B Ratio of 8.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.45% of the float of Joint has been sold short.

Short Interest Ratio / Days to Cover

Joint has a short interest ratio ("days to cover") of 4.89.

Change versus previous month

Short interest in Joint has recently increased by 9.96%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Joint does not currently pay a dividend.

Dividend Growth

Joint does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.60

News Sentiment

Joint has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Joint this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Joint insiders have not sold or bought any company stock.

Percentage Held by Insiders

30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/25/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:JYNT
• CIK: 1612630
• Web: www.thejoint.com
• Phone: (480) 245-5960
• Fax: 480-513-7989
• Employees: 330
• Year Founded: 1999

Profitability

• EPS (Trailing Twelve Months): $0.27
• Trailing P/E Ratio: 30.17
• Forward P/E Ratio: 26.36
• P/E Growth: N/A
• Net Income: $2.91 million
• Net Margins: 6.49%
• Pretax Margin: 3.61%
• Return on Equity: 12.02%
• Return on Assets: 3.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.83
• Quick Ratio: 1.83

Sales & Book Value

• Annual Sales: $54.90 million
• Price / Sales: 2.11
• Cash Flow: $0.09 per share
• Price / Cash Flow: 86.15
• Book Value: $1.01 per share
• Price / Book: 8.09

Miscellaneous

• Outstanding Shares: 14,140,000
• Free Float: 9,872,000
• Market Cap: $115.57 million
• Optionable: Optionable
• Beta: 1.05